Catalyst Wire Dossier Catalyst Wire Dossier

KINE-101

· Kine Sciences Co., Ltd.
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for KINE-101, covering 2026-01-07 to 2026-01-20. Get the full timeline:

Most recent: Clinical Trial Update: A First-in-Patient Clinical Trial of KINE-101 in Patients With Corticosteroid-Refractory CIDP [Phase 1]

See pricing